Article Information
History
- May 24, 2020.
Article Versions
- Version 1 (March 13, 2020 - 04:12).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Chong Lei1,
- Binxiao Su1,2,
- Hailong Dong1,
- Andrea Bellavia3,
- Raffaele Di Fenza4,5,
- Bijan Safaee Fakhr4,
- Stefano Gianni4,
- Luigi Giuseppe Grassi4,
- Robert Kacmarek4,
- Caio Cesar Araujo Morais4,
- Riccardo Pinciroli4,
- Emanuele Vassena4 and
- Lorenzo Berra4,*
- 1Department of Anesthesiology and Perioperative Medicine, Xijing Hospital, the Fourth Military Medical University. Xi’an, Shaanxi, China.
- 2Intensive Care Unit, Department of Anesthesiology and Perioperative Medicine, Xijing Hospital, the Fourth Military Medical University. Xi’an, Shaanxi, China.
- 3Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA
- 4Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
- 5University of Milan-Bicocca, Milan-Italy
- ↵*Correspondence to Dr. Chong LEI, crysta.Heichong{at}126.com and Dr. Lorenzo Berra, lberra{at}mgh.harvard.edu.
Posted May 24, 2020.
Protocol of a randomized controlled trial testing inhaled Nitric Oxide in mechanically ventilated patients with severe acute respiratory syndrome in COVID-19 (SARS-CoV-2)
